Publications

  • Hergenrather, J. Y., Aviram, J., Vysotski, Y., Campisi-Pinto, S., Lewitus, G. M., & Meiri, D. (2020). Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients. Rambam Maimonides medical journal, 11(1).

  • Aviram, J., Lewitus, G. M., Vysotski, Y., Uribayev, A., Procaccia, S., Cohen, I., … & Meiri, D. (2020). Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients. Pharmaceuticals, 13(12), 435.

  • Bar-Sela, G., Cohen, I., Campisi-Pinto, S., Lewitus, G. M., Oz-Ari, L., Jehassi, A., … & Wollner, M. (2020). Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers12(9), 2447.

  • Sznitman, S. R., Vulfsons, S., Meiri, D., & Weinstein, G. (2020). Medical cannabis and cognitive performance in middle to old adults treated for chronic pain. Drug and alcohol review.

  • Aviram, J., Pud, D., Gershoni, T., Schiff‐Keren, B., Ogintz, M., Vulfsons, S., … & Goor‐Aryeh, I. (2020). Medical Cannabis Treatment for Chronic Pain: Outcomes and Prediction of Response. European Journal of Pain.

  • Milay, L., Berman, P., Shapira, A., Guberman, O., & Meiri, D. (2020). Metabolic profiling of Cannabis secondary metabolites for evaluation of optimal postharvest storage conditions. Frontiers in plant science11.

  • Aviram, J., Vysotski, Y., Berman, P., Lewitus, G. M., Eisenberg, E., & Meiri, D. (2020). Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study. Brain Sciences10(6), 360.

  • McGarvey, P., Huang, J., McCoy, M., Orvis, J., Katsir, Y., Lotringer, N., … & Meiri, D. (2020). De novo assembly and annotation of transcriptomes from two cultivars of Cannabis sativa with different cannabinoid profiles. Gene, 145026.

  • Berman, P., Sulimani, L., Gelfand, A., Amsalem, K., Lewitus, G. M., & Meiri, D. (2020). Cannabinoidomics–An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome. Talanta , 121336.

  • Sznitman, S. R., Vulfsons, S., Meiri, D., & Weinstein, G. (2020). Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study. BMJ Supportive & Palliative Care.

  • Uziel, A., Gelfand, A., Amsalem, K., Berman, P., Lewitus, G. M., Meiri, D., & Lewitus, D. Y. (2020). Full-Spectrum Cannabis Extract Microdepots Support Controlled Release of Multiple Phytocannabinoids for Extended Therapeutic Effect. ACS Applied Materials & Interfaces.

  • Shapira, A., Berman, P., Futoran, K., Guberman, O., & Meiri, D. (2019). Tandem mass spectrometric quantification of 93 terpenoids in Cannabis using static headspace (SHS) injections. Analytical chemistry.

  • Taha, T., Meiri, D., Talhamy, S., Wollner, M., Peer, A., & Bar‐Sela, G. (2019). Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies. The oncologist24(4), 549-554.

  • Baram, L., Peled, E., Berman, P., Yellin, B., Besser, E., Benami, M., Louria-Hayon, I., Lewitus, G.M. and Meiri, D. (2019). The heterogeneity and complexity of Cannabis extracts as antitumor agents. Oncotarget, 10(41), p.4091.

  • Berman P., Furoan K., M. Lewitus G., Mukha D., Benami M., Shlomi T., Meiri D. (2018) A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis. Scientific Reports. 8(1):14280.

  • Mokady D., Meiri D. (2014) RhoGTPases- a novel link between cytoskeleton organization and cisplatin resistance. Drug Resistance Updates (impact factor 9.96).

  • Meiri D., Marshall CB., LaRose J., Gingras AC., Ikura M., Robert Rottapel. (2014) Mechanistic insight into the GPCR-mediated activation of the microtubule-associated RhoA-specific guanine exchange factor, GEF-H1. Nature Communications 11(5):4857.

  • Cullis J*., Meiri, D*., Radulovich N., LaRose J., Medrano M., Marcotte R., Marshall C.B.,  Moffat J., Neel B., Gingras AC., Robert Rottapel (2014) The RhoGEF GEF-H1 is required for RAS oncogene-driven pancreatic cancer. Cancer cell 25(2):181-95.
    *These authors contributed equally to the work.

  • Lighezan L., Meiri, D., Breiman A., Neagu A. (2013) Circular dichroism and the secondary structure of the ROF2 protein from Arabidopsis thaliana. J Biol Phys. 39(4):635-48.

  • Marshall, C.B., Meiri, D., Smith, M.J., Mazhab-Jafari, M.T., Gasmi-Seabrook, G.M., Rottapel R., Stambolic, V., and Ikura, M. (2012). Probing the GTPase cycle with real-time NMR: GAP and GEF activities in cell extracts. Methods. 57, 473-85.

  • Meiri D., Marshall CB., Greeve, M.A., Bakal C., Kim B., Suarez F., LaRose J., Fine N.,  Ikura, M.,  and Rottapel R. (2011). Mechanistic insight into the microtubule and actin cytoskeleton coupling through dynein dependent RhoGEF inhibition. Mol Cell 45, 642-55.

  • Cohen-Peer R, Schuster S, Meiri D, Breiman A., and Avni A. (2010). Sumoylation of Arabidopsis heat shock factor A2 (HsfA2) modifies its activity during acquired thermotholerance. Plant Mol Biol 74, 33-45.

  • Meiri, D., Tazat, K., Cohen-Peer, R., Farchi-Pisanty, O., Aviezer-Hagai, K., Avni, A., and Breiman, A. (2010). Involvement of Arabidopsis ROF2 (FKBP65) in thermotolerance. Plant Mol Biol 72, 191-203.

  • Meiri, D., Greeve, M.A., Brunet, A., Finan, D., Wells, C.D., LaRose, J., and Rottapel, R. (2009). Modulation of Rho guanine exchange factor Lfc activity by protein kinase A-mediated phosphorylation. Mol Cell Biol. 29, 5963-5973.

  • Meiri, D. and Breiman, A. (2009). Arabidopsis ROF1 (FKBP62) modulates thermotolerance by interacting with HSP90.1 and affecting the accumulation of HsfA2-regulated sHSPs. Plant J. 59, 387-99